Research ArticleArticle
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010–2013
Ginger Janow, Laura E. Schanberg, Soko Setoguchi, Victor Hasselblad, Elizabeth D. Mellins, Rayfel Schneider, Yukiko Kimura and the CARRA Legacy Registry Investigators
The Journal of Rheumatology June 2016, jrheum.150997; DOI: https://doi.org/10.3899/jrheum.150997
Ginger Janow
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Laura E. Schanberg
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Soko Setoguchi
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Victor Hasselblad
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Elizabeth D. Mellins
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Rayfel Schneider
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Yukiko Kimura
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
From the Pediatrics, Joseph M. Sanzari Children’s Hospital, Hackensack, New Jersey; Pediatrics, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina; Pediatrics, Stanford University, Stanford, California, USA; Pediatrics, Hospital for Sick Children; University of Toronto, Toronto, Ontario, Canada. Novartis Pharmaceutical Corporation provided an unrestricted grant to fund this research. These authors received grant/research support from Novartis: L.E. Schanberg, S. Setoguchi, and E.D. Mellins. R. Schneider received grant/research support from Novartis, and is a consultant for Novartis. Y. Kimura received grant/research support from Novartis, and is a consultant for Novartis. Dr. Mellins’s work is supported by the University of California at San Francisco–Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation. The Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA) Legacy Registry was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Friends of CARRA, the Arthritis Foundation, and the National Institutes of Health (RC2AR058934). G. Janow, MD, MPH, Pediatrics, Joseph M. Sanzari Children’s Hospital; L.E. Schanberg, MD, Pediatrics, Duke University, and the Duke Clinical Research Institute; S. Setoguchi, MD, PhD, Duke Clinical Research Institute; V. Hasselblad, PhD, MS, Duke Clinical Research Institute; E.D. Mellins, MD, Pediatrics, Stanford University; R. Schneider, MD, Pediatrics, Hospital for Sick Children, and the University of Toronto; Y. Kimura, MD, Pediatrics, Joseph M. Sanzari Children’s Hospital. Dr. Mellins, Dr. Schneider, and Dr. Kimura share senior authorship. Address correspondence to Dr. G. Janow, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey 07601, USA. E-mail: gjanow@hackensackumc.org. Accepted for publication May 19, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010–2013
Ginger Janow, Laura E. Schanberg, Soko Setoguchi, Victor Hasselblad, Elizabeth D. Mellins, Rayfel Schneider, Yukiko Kimura, the CARRA Legacy Registry Investigators
The Journal of Rheumatology Jun 2016, jrheum.150997; DOI: 10.3899/jrheum.150997
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010–2013
Ginger Janow, Laura E. Schanberg, Soko Setoguchi, Victor Hasselblad, Elizabeth D. Mellins, Rayfel Schneider, Yukiko Kimura, the CARRA Legacy Registry Investigators
The Journal of Rheumatology Jun 2016, jrheum.150997; DOI: 10.3899/jrheum.150997